Anas Al Bawaliz
Hematology & Oncology · Louisville, KYNPI 1518452127
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,503 and has fallen 91.4% since, to $130 in 2025. That places this record below the midpoint for hematology & oncology clinicians in KY, where the typical reported total is $4,619.
Across 139 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$387
- Daiichi Sankyo Inc.$300
- E.r. Squibb & Sons, L.L.C.$250
- Amgen$232
- Seagen Inc.$181
- Genentech USA, Inc.$148
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,81394%
- Education$1756%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $387 |
| Daiichi Sankyo Inc. | 13 | $300 |
| E.r. Squibb & Sons, L.L.C. | 15 | $250 |
| Amgen | 9 | $232 |
| Seagen Inc. | 12 | $181 |
| Genentech USA, Inc. | 1 | $148 |
| Pfizer | 6 | $140 |
| AbbVie | 7 | $133 |
| Sobi, Inc | 5 | $105 |
| Merck | 6 | $100 |
| Rigel Pharmaceuticals, Inc. | 4 | $95 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $93 |
| AVEO Pharmaceuticals, Inc. | 1 | $75 |
| Bayer | 3 | $72 |
| AstraZeneca(2 entities) | 3 | $69 |
| Pharmacosmos Therapeutics Inc. | 3 | $66 |
| Beigene USA, Inc. | 4 | $55 |
| ADC Therapeutics America, Inc. | 3 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Johnson & Johnson | 2 | $47 |
| Boehringer Ingelheim | 3 | $43 |
| Incyte Corporation | 2 | $42 |
| Stemline Therapeutics Inc. | 2 | $38 |
| Mirati Therapeutics, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Sanofi | 1 | $27 |
| Gilead | 1 | $25 |
| Adaptive Biotechnologies Corporation | 1 | $23 |
| Eisai Inc. | 1 | $20 |
| Puma Biotechnology, Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Apellis Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$2,988 in reported general payments places this provider in the 35th percentile of 143 hematology & oncology providers in Kentucky.
Other hematology & oncology in Louisville
- Vivek SharmaLouisville$647K
- Goetz KloeckerLouisville$584K
- Jeffrey HargisLouisville$450K
- Mohamed HegaziLouisville$380K
- Khuda KhanLouisville$359K
- Jaspreet GrewalLouisville$280K
- Laila AgrawalLouisville$95K
- Brian DongLouisville$31K
- Rohit KumarLouisville$31K
- Vikas SinghLouisville$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.